Collectively, these results highlight the potential of pharmacological intervention against LPA signaling for blunting senescence-associated loss of function characteristic of human MSCs. Introduction Stem/progenitor cells are the subject of intense investigation for cell-based therapies [1]. all panels, the data are presented as the means standard error (values compared to controls Continue Reading